Precision BioSciences (DTIL): Operatsion rentabellik

Precision BioSciences, Inc. (DTIL) - korporativ logo

Precision BioSciences aniq CAR-T terapiyalarini ishlab chiqish va genetik patologiyalarni davolash uchun innovatsion ARCUS platformasini joriy qilmoqda. Tadqiqotlar barqarorligi laboratoriyalarni diversifikatsiya qilish va reagentlarni havo transporti orqali tashish orqali ta'minlanadi. Biroq, geosiyosiy keskinliklar patent himoyasi va xalqaro importni murakkablashtirmoqda. Choraklik operatsion marja biznes samaradorligini aks ettiradi, bunda oxirgi qiymat -80.30 deb qayd etilgan bo'lib, bu bozor shoklariga chidamlilikni namoyish etadi.

DTIL: Precision BioSciences Inc. Sotuvning operatsion marjasi 04.07.2022 - 19.11.2026

precisionbiosciences.com (DTIL) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:precisionbiosciences.com, DTIL
Precision BioSciences tayyor mahsulotlari

DNA terapiyalarini ishlab chiqishni tezlashtirish uchun avtomatlashtirilgan ARCUS stantsiyalarining joriy etilishi Precision BioSciences (DTIL) kompaniyasining xarajatlar tuzilmasiga bevosita ta'sir ko'rsatadi. Operatsion foyda marjasi tendentsiyasi foizlar va soliqlar to'lanishidan oldingi daromadga nisbatan bazaviy xarajatlarni boshqarish samaradorligini namoyish etadi, bu esa investorlarga ushbu grafik tahlili orqali asosiy biznesning haqiqiy daromadli ekanligini va uning operatsion modelining barqarorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik